PubMed · 6913854
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
J A Critchley. 1981. Working with beryllium.. https://pubmed.ncbi.nlm.nih.gov/6913854/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
PURPOSE: To determine the relationship between photon sensitivity and neutron sensitivity and between neutron RBE and photon resistance for two neutron modalities (with mean energies of 6 and 29 MeV) using human tumor cell lines spanning a wide range of radiosensitivities, the principal objective being whether or not a neutron advantage can be demonstrated. METHODS AND MATERIALS: Eleven human tumor cell lines with mean photon inactivation doses of 1.65-4. 35 Gy were irradiated with 0-5.0 Gy of p(66)/Be neutrons (mean energy of 29 MeV) at Faure, S.A. and the same plating was irradiated on the same day with 0-10.0 Gy of Cobalt-gamma-rays. Twelve human tumor cell lines, many of which were identical with the above selection, and spanning mean photon inactivation doses of 1.75-4.08 Gy, were irradiated with 0-4 Gy of d(14)/Be neutrons (mean energy of 6 MeV) and with 0-10 Gy of 240 kVp X-rays at the Essen Klinikum. Cell survival was determined by the clonogenic assay, and data were fitted to the linear quadratic equation. RESULTS: 1. Using the mean inactivation dose, a significant correlation was found to exist between neutron sensitivity and photon sensitivity. However, this correlation was more pronounced in the Faure beam (r(2) = 0.89, p </= 0.0001) than in the Essen beam (r(2) = 0.65, p = 0.0027). 2. No significant relationship could be established between neutron RBE and photon resistance for both modalities (p = 0.69 and p = 0.07, respectively). 3. Using alpha-coefficients as a criterion, the neutron sensitivity for the Faure beam correlated with photon sensitivity (p = 0.001), but this did not apply to the Essen beam (p = 0.27). 4. The neutron RBE for the Essen beam derived from alpha-coefficients showed a steep increase with photon resistance (p = 0.003). In the Faure beam there was no increase of RBE with photon resistance (p = 0.494). CONCLUSION: Radiobiological differences between high-energy and low-energy neutrons are particularly apparent in the dependence of the neutron RBE on photon sensitivity. The increase of RBE with photon resistance is more pronounced in the low-energy Essen neutrons than in the high-energy Faure neutrons. An RBE advantage is indicated for photon-resistant cell lines and this is particularly apparent in the low-dose range using alpha-coefficients as compared to the mean inactivation dose. The clinical application of low-energy neutrons may be more restricted because of poor penetration and lack of skin sparing. However, these neutrons discriminate better between photon-sensitive and photon-resistant cells giving an RBE range of 2-6 and a mean RBE of 4.1, than high-energy neutrons where the RBE range is 1.6-3.5 and the mean RBE is 2.4. From the radiobiological point of view it, therefore, appears that the clinical potential of low-energy neutrons is considerably underrated.
High-performance chelation ion chromatography (HPCIC), involving a chelating silica substrate bonded with aminomethylphosphonic acid, has been developed as a novel technique for the quantitative determination of beryllium in complex matrices. An isocratic separation method, using an eluent containing 1 M KNO3, 0.5 M HNO3 and 0.08 M ascorbic acid, allowed the Be2+ to elute away from the sample matrix peak in under 6 min in a sample containing in excess of 800 mg l(-1) matrix metals. A detection limit of 35 microg l(-1) Be(II) was found using a post-column reaction involving Chrome Azurol S (CAS), 1 M hexamine and 10 mM EDTA buffered at pH 6. The standard addition curve gave excellent linearity (R2>0.999). The procedure was applied to the determination of trace beryllium in a certified sediment sample. The results obtained compared well with the certified value for beryllium.
In an overall evaluation of the situation published by IARC in 1993, beryllium and beryllium compounds are identified as carcinogens to humans. This prompted the initiation of this study on beryllium which reviews the situation up to 1998 on the aspects: properties and applications, toxicity, analytical procedures for food and drinking water, reference materials, occurrence in food and drinking water and estimates of daily dietary exposure. Special emphasis is put on analytical aspects and levels of beryllium in food and drinking water.